| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Bankruptcy > If You're Looking for an Alternative to Bankruptcy an IVA Could be the Answer |
|
Just Other Articles - If You're Looking for an Alternative to Bankruptcy an IVA Could be the Answer
IVA- An Alternative to Bankruptcy For many people the idea of going bankrupt feels them with horror According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product - and it’s not difficult to understand why. Going bankrupt has all sorts of social stigmas associated with ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t, not to mention a whole host of disadvantages and disqualifications. No wonder then that the IVA, introd lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. uced by the government in 1986, is so attractive since it offers a good and legitimate alternative to bankr here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ptcy. Why Seek an Alternative to Bankruptcy Bankruptcy has numerous disadvantages associated with d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro it which means that an alternative should be sought if at all possible. As well as the social stigma attac ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ed to bankruptcy, there are a number of disqualifications attached to it such as: • People who are declare easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d bankrupt lose their professional and business status • Bankrupts are not allowed to hold public office nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically If you are made bankrupt you have to hand over your valuable assets to the trustee (including your home) and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ • Future employment prospects are prejudiced by bankruptcy • Bankrupts cannot form, manage or promote a bu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi iness without the court’s permission Why an IVA is a Good Alternative to Bankruptcy An IVA does no ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t have any of the social stigmas, disqualifications or disadvantages associated with bankruptcy. This makes dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod it a good alternative to bankruptcy. IVAs were actually introduced initially as an alternative to bankrupt cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin cy. They are popular because they offer a good alternative to bankruptcy for both debtors and creditors. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rom a creditor’s point of view, an IVA is a good alternative to bankruptcy because there are no fees or leg t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel al proceeding involved with it.Moreover, an IVA offers a greater repayment of the debt than would possible ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust f the debtor was made bankrupt. From the debtor’s perspective, an IVA is a good alternative to bankruptcy y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products because it lacks stigmas and disqualifications. Plus with an IVA, it is not unusual for up to 80% of a debt . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to be written off. Who is an IVA Suitable For An IVA is a suitable alternative to bankruptcy elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip > for people with debts over ?15,000, multiple creditors and who can afford to re-pay at least ?200 a month tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|